European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesRobert Knobler, Thomas Krieg, Christopher P. Denton et al.|Journal of the European Academy of Dermatology and Venereology|2017Cited by 261
Endothelial Injury in a Transforming Growth Factor β–Dependent Mouse Model of Scleroderma Induces Pulmonary Arterial HypertensionEmma Derrett‐Smith, Christopher P. Denton|Arthritis & Rheumatism|2013Cited by 55
Clinical and pathogenic significance of S100A4 overexpression in systemic sclerosisChristopher P. Denton, Voon H Ong|Annals of the Rheumatic Diseases|2023Cited by 10
Prostacyclin mimetics inhibit DRP1-mediated pro-proliferative mitochondrial fragmentation in pulmonary arterial hypertensionJeries Abu‐Hanna, Lucie H. Clapp, Evangelos Anastasakis et al.|Vascular Pharmacology|2023Cited by 8